Peripheral Artery Disease News and Research

RSS
Peripheral arterial disease (PAD) occurs when leg arteries become narrowed or blocked by plaque. These blockages can result in severe pain for patients, limited physical mobility, and life-threatening non-healing leg ulcers. According to the American Heart Association, this condition affects approximately 8 to 12 million Americans. With only about 25 percent of PAD patients undergoing treatment, it is a disease that is largely under-diagnosed and under-treated. If left untreated, PAD can lead to critical leg ischemia, a condition where not enough blood is being delivered to the leg to keep the tissue alive. Total loss of circulation to the legs and feet can cause gangrene and lead to amputation.
ACIST Medical Systems announces debut of next generation FFR solution

ACIST Medical Systems announces debut of next generation FFR solution

Stem cell researchers make advance toward long-lasting blood vessel repair

Stem cell researchers make advance toward long-lasting blood vessel repair

Biomaterial-mediated growth factor delivery can restore perfusion of blood vessels in animal models

Biomaterial-mediated growth factor delivery can restore perfusion of blood vessels in animal models

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Drug combination superior in preventing further heart complications in people with vascular disease

Drug combination superior in preventing further heart complications in people with vascular disease

ESC recommendations on management of patients with peripheral arterial diseases published

ESC recommendations on management of patients with peripheral arterial diseases published

Study shows how hyperglycemia following surgery for PAD affects post-surgical outcomes

Study shows how hyperglycemia following surgery for PAD affects post-surgical outcomes

Findings highlight need to improve quality of care for high-risk patients with peripheral artery disease

Findings highlight need to improve quality of care for high-risk patients with peripheral artery disease

Knocking out lipid-modifying enzyme can boost post-heart attack healing, study shows

Knocking out lipid-modifying enzyme can boost post-heart attack healing, study shows

Study reveals brain activity may be key to link between stress and heart disease

Study reveals brain activity may be key to link between stress and heart disease

Hospitals eliminate bedsore occurrence using early detection technology

Hospitals eliminate bedsore occurrence using early detection technology

OrbusNeich launches new Dual Therapy Stent for active vessel healing

OrbusNeich launches new Dual Therapy Stent for active vessel healing

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

UNC scientists find clue that may help explain why people differ in ability to survive arterial blockages

UNC scientists find clue that may help explain why people differ in ability to survive arterial blockages

Transplantation of placenta-derived MSCs can prevent diabetes-related CLI in rats

Transplantation of placenta-derived MSCs can prevent diabetes-related CLI in rats

MILabs to provide new hybrid imaging system to Yale for advancing cardiovascular research

MILabs to provide new hybrid imaging system to Yale for advancing cardiovascular research

Maternal placental syndromes increase short-term risk of developing cardiovascular disease

Maternal placental syndromes increase short-term risk of developing cardiovascular disease

Breakthrough research could lead to new drugs to improve heart attack outcomes

Breakthrough research could lead to new drugs to improve heart attack outcomes

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD